APSR2026-113

Yes
Late-Breaking
Submitted
Oral Presentation
AO09-003
 
 
https://storage.unitedwebnetwork.com/files/1285/1207056-46903-APSR2026-113_439769.pptx
Format: PPTX Only
 
Format: PDF Only
01. Clinical Respiratory Medicine
10

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Osamu Kanai * National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Naoki Fujimoto - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Saiki Yoshimura - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Yuta Okada - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Shogo Toyama - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Takanori Ito - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Takuma Imakita - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Issei Oi - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Kohei Fujita - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
Kiminobu Tanizawa - National Hospital Organization Kyoto Medical Center Respiratory Medicine Kyoto Japan
 
 
 
 
 
Presenting Author Details
Osamu
Kanai
okanai.kmc@gmail.com
+817083678991
41-50
Japan
Original Research
Safety of CT-guided percutaneous core-needle biopsy for targets away from the pleura
Maximum 25 words
Abstract Content
The incidence of CT-guided percutaneous core-needle biopsy (PCNB)-induced pneumothorax has been reported to be associated with the depth of targets. However, we hypothesized that contacting with the pleura or not is the true factor associated with the incidence of pneumothorax. To test these hypotheses, we investigated the association between the incidence of CT-guided PCNB-induced pneumothorax and the depth from the pleura to target lesion.
We retrospectively reviewed patients who underwent CT-guided PCNB for targets away from the pleura between 2017 and 2024. We evaluated the incidence of pneumothorax by a depth of targets from the pleura. Multivariable analysis was performed by estimating prevalence ratios (PR) and 95%-confidence intervals (CI) using Modified Poisson regression analysis adjusted by ECOG-PS, comorbidity with diabetes, emphysema, or interstitial pneumonia, antiplatelet use, prone position, targets in the lower lung field, longest diameter ≤20 mm, solid type of targets, and hemoptysis.
Among 248 patients who underwent CT-guided PCNB, 120 (48.4%) patients developed pneumothorax. The mean depths from the pleura to target were 22.2 mm in the Pneumothorax group and 22.3 mm in the No pneumothorax group (P=0.941). The incidences of pneumothorax were 53.8% in those with a depth ≤15 mm, 41.5% in those with a depth ≤25 mm, and 50.0% in those with a depth >25 mm (P=0.268). Patients with hemoptysis after CT-guided PCNB had significantly lower incidence of pneumothorax [1 (0.8%) versus 9 (7.0%) patients, P=0.020]. On multivariable analysis, a depth ≤25 mm (PR; 0.84, 95%-CI; 0.62-1.14) and >25 mm (PR; 1.02, 95%-CI; 0.77-1.35) showed no significant association with the incidence of pneumothorax compared with a depth ≤15 mm.
A depth from the pleura to target lesion was not associated with the incidence of pneumothorax by CT-guided PCNB for targets away from the pleura.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Complication, Percutaneous needle biopsy, Pneumothorax
maximum 3 keywords and no abbreviations, separated by commas
There is no conflict of interest to declare.
312